Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing surgical site infections in paediatric cardiac surgery in a resource-constrained setting: a quality improvement initiative.

BMJ open quality·2026
Same author

First-in-Human Innovative Modification of the Harmony™ Transcatheter Pulmonary Valve to Accommodate Short Right Ventricular Outflow Tract Anatomy in Patients With Severe Pulmonary Regurgitation.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Pediatric Cardiology Training and Certification in Latin America and the Caribbean: A Cross-Sectional Regional Survey of Current Practice.

Pediatric cardiology·2026
Same author

Managing Unrepaired Tetralogy of Fallot in Pregnancy: A Rare Case Defying Standard Cardiac Guidelines.

JACC. Case reports·2025
Same author

Confronting Global Inequity in Pediatric Cardiac Care: From Crisis to Opportunity.

Journal of the American College of Cardiology·2025
Same author

Outcomes and Risk Factors of Transcatheter Interventions to Create or Enlarge an Atrial Communication.

Pediatric cardiology·2025

Related Experiment Video

Updated: May 12, 2026

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

27.9K

Biosensors with left ventricular assist devices.

Mahmoud Abbassy1, Muhammad Zain Ali2, Riya Manas Sharma1

  • 1School of Medicine, RCSI University of Medicine and Health Sciences, Dublin 2, Dublin, Ireland.

Heart Failure Reviews
|June 28, 2024
PubMed
Summary

Implanted biosensors can monitor heart failure patients with mechanical circulatory support devices (MCSDs), like left ventricular assist devices (LVADs). This continuous monitoring aids early detection of issues, improving patient outcomes.

Keywords:
Implantable biosensorLeft ventricular assist device (LVAD)Percutaneous biosensorPressure sensor

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.6K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.9K

Related Experiment Videos

Last Updated: May 12, 2026

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

27.9K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.6K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.9K

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Medicine
  • Materials Science

Background:

  • Heart failure presents a major global health challenge, contributing significantly to mortality.
  • Biochemical and physiological indicators can signal distinct cardiac conditions.
  • Mechanical circulatory support devices (MCSDs), including left ventricular assist devices (LVADs), are vital for managing advanced heart failure.

Purpose of the Study:

  • To review biosensors suitable for integration with LVADs for monitoring critical biomarkers and physiological parameters.
  • To discuss fabrication materials, advantages, and disadvantages of these biosensors.
  • To examine the feasibility of using biosensor data for closed-loop control in LVAD systems.

Main Methods:

  • Literature review of existing biosensor technologies applicable to MCSDs.
  • Analysis of biosensor fabrication materials and their properties.
  • Exploration of control system integration strategies using real-time biosensor data.

Main Results:

  • Various biosensors show potential for implantation alongside LVADs to track biochemical and physiological changes.
  • Different materials offer unique benefits and drawbacks for biosensor construction.
  • Integration of biosensors enables continuous monitoring and potential for closed-loop control of LVADs.

Conclusions:

  • Implanted biosensors offer a promising avenue for enhanced monitoring of patients with LVADs.
  • Early detection of adverse changes through continuous monitoring can improve patient prognosis.
  • Future research should focus on overcoming challenges in integrating biosensors for effective closed-loop control systems.